About THINQ Pharma
THINQ Pharma is a Healthcare company based in Thane (India) founded in 1989. It manufactures pharmaceutical formulations, APIs, and offers RD and regulatory services worldwide. It operates on a B2B model. The company has 141 employees. Its Indian entity Thinq Pharma-Cro Limited reported revenue of ₹62.89 Cr. THINQ Pharma offers products and services including Formulations, APIs, Advanced Intermediates, and Natural Products. Its focus areas include Pharmaceuticals, Formulation Development, Drug Formulations and API Manufacturing. Similar companies include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed similar companies has raised funding.
Company details
THINQ Pharma is an integrated pharmaceutical company that develops and manufactures formulations, APIs, and advanced intermediates through advanced RD and production facilities. It provides services like generic formulation development, manufacturing, marketing, and clinical data management. Based in India, the company focuses on technology-driven innovation for health products, serving global markets with a vertically integrated approach to ensure quality and efficiency.
- Headquarters Thane, India
- Employees 141
- SectorsHealthcare
- Email••••••••
- Website thinqcro.com
- Social Facebook
- Legal Name Thinq Pharma-Cro Limited
- Date of Incorporation 10 Nov, 2006
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹62.89 Cr
FY 2025 · +17% YoY
- Net Profit₹3.97 Cr
FY 2025 · 6% margin
- EBITDA₹10.91 Cr
FY 2025 · 17% margin
- Employee Count141
Associated legal entities of THINQ Pharma
THINQ Pharma operates through Thinq Pharma-Cro Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Thinq Pharma-Cro Limited CIN U24239MH2006PLC165473 | Active | 10 Nov 2006 | Mumbai, Maharashtra | ₹62.9 Cr | 148 | 3 | View details |
Products & Services of THINQ Pharma
THINQ Pharma offers a comprehensive portfolio of products and services, including Formulations, APIs, Advanced Intermediates, and Natural Products.
Develops various formulations for health applications.
Produces active pharmaceutical ingredients for global supply.
Creates intermediates for pharmaceutical manufacturing processes.
Offers natural and sports nutrition range for health needs.
Board of directors of Thinq Pharma-Cro Limited (THINQ Pharma)
Thinq Pharma-Cro Limited is the primary company behind THINQ Pharma. The board of Thinq Pharma-Cro Limited currently have 3 directors; the longest-serving is Chandrashekhar Shankar Nadkarni, appointed in 2006. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandrashekhar Shankar Nadkarni DIN 00780294 | Managing Director | 10 Nov 2006 | 19 yrs 11 mo | Thinq Pharma-Cro Limited |
| Rohit Ramakant Gulgule DIN 01256887 | Director | 10 Nov 2006 | 19 yrs 11 mo | Thinq Pharma-Cro Limited |
| Ravindra Ramakant Gulgule DIN 03629811 | Director | 15 Sep 2011 | 15 yrs 1 mo | Thinq Pharma-Cro Limited |
Financials of THINQ Pharma
Figures of Thinq Pharma-Cro Limited, the primary company behind THINQ Pharma, for FY 2025. Revenue was ₹62.89 Cr (+17% year on year). Net profit was ₹3.97 Cr (6% margin). EBITDA was ₹10.91 Cr (17% margin). Revenue has grown at a compounded annual rate of 0% over three years and +1% over five years.
- ₹62.89 CrRevenue · FY 2025 · +17% YoY
- ₹3.97 CrNet profit · 6% margin
- ₹10.91 CrEBITDA · 17% margin
- ₹5 LakhPaid-up capital
- 148Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Thinq Pharma-Cro Limited are on its company page.
Detailed financial statements for THINQ Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to THINQ Pharma
THINQ Pharma has 3 listed similar companies in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed similar companies of THINQ Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of THINQ Pharma
The website of THINQ Pharma (thinqcro.com) receives about 1K visits a month.
- Monthly visits1K
▲ 5.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about THINQ Pharma
THINQ Pharma was founded in 1989.
THINQ Pharma is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
THINQ Pharma has 141 employees.
The primary company behind THINQ Pharma, Thinq Pharma-Cro Limited, reported revenue of ₹62.89 Cr for FY 2025, up 17% year on year.
THINQ Pharma is an integrated pharmaceutical company that develops and manufactures formulations, APIs, and advanced intermediates through advanced RD and production facilities. It provides services like generic formulation development, manufacturing, marketing, and clinical data management. Based in India, the company focuses on technology-driven innovation for health products, serving global markets with a vertically integrated approach to ensure quality and efficiency.
THINQ Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
THINQ Pharma offers Formulations, APIs, Advanced Intermediates, and Natural Products.
THINQ Pharma operates through Thinq Pharma-Cro Limited.
The legal entities of THINQ Pharma currently have 3 directors, including Chandrashekhar Shankar Nadkarni, Ravindra Ramakant Gulgule, Rohit Ramakant Gulgule.